Patient Education

Keeping your patients educated

To help you communicate more effectively with
your patients about emergency contraception and
Next Choice®, please use the support materials available below. To download these materials, simply click on the items below. Printed versions of these pieces can also be ordered by calling 866-9WATSON.

Patient Leaflet/English
Patient Leaflet/En Español
Prescriber's Flash Card

You need Adobe® Reader® installed on your computer to view these materials, or download a copy of the Adobe® Reader® by clicking the icon below.

Important Safety Information

Next Choice® should not be used by women with a known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice should be evaluated for ectopic pregnancy. Next Choice is not effective in terminating an existing pregnancy, and does not protect against STI/HIV. Next Choice may alter the next expected menses, however, if menses is delayed beyond 1 week, pregnancy should be considered. The most common adverse reactions in the clinical trial were menstrual changes (26%), nausea (23%), abdominal pain (18%), fatigue (17%), headache (17%), dizziness (11%), and breast tenderness (11%).

To report side effects of prescription drugs to the FDA, visit fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Next Choice, please call our Medical Communications Department at 866-9WATSON.

This Web site is intended for United States Prescribers, Pharmacists & Consumers.